# Metformin And Longevity

> **NCT02511665** · PHASE4 · UNKNOWN · sponsor: **Guy's and St Thomas' NHS Foundation Trust** · enrollment: 185 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Metformin
- **RADIATION:** PET-MRI Scan
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02511665
- **Lead sponsor:** Guy's and St Thomas' NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-07
- **Primary completion:** 2017-07
- **Final completion:** 2017-07
- **Target enrollment:** 185 (ESTIMATED)
- **Last updated:** 2015-07-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02511665

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02511665, "Metformin And Longevity". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02511665. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*